公开(公告)号：AU2016353229B2

公开(公告)日：2021-05-06

申请号：AU2016353229

申请日：2016-11-11

Applicant: MICROOPTX INC

Inventor： MARTIN ROY CHRISTIAN ,  PULLING CHRISTOPHER CLARK ,  MARTIN CHRISTOPHER THOMAS ,  BROWN J DAVID

IPC: A61B3/12 ,  A61B5/1455 ,  A61B5/1459

Abstract: A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.

公开(公告)号：AU2017293767B2

公开(公告)日：2021-12-16

申请号：AU2017293767

申请日：2017-07-05

Applicant: MICROOPTX INC

Inventor： BROWN J DAVID ,  PULLING CHRISTOPHER CLARK ,  MARTIN ROY CHRISTIAN ,  COHEN EDWARD AARON

IPC: A61M1/00 ,  A61F9/00

Abstract: Devices can be implanted in an eye to treat glaucoma and/or dry eye. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. The body can include a radiused distal edge. A distal end portion of the body can be laterally flared. The body can include a mid-body portion that is laterally narrower than distal and proximal end portions of the body. Methods of treating glaucoma and/or dry eye, wherein the device is implanted in the sclera of an afflicted eye, are also described.

公开(公告)号：AU2017293767A1

公开(公告)日：2019-01-03

申请号：AU2017293767

申请日：2017-07-05

Applicant: MICROOPTX INC

Inventor： BROWN J DAVID ,  PULLING CHRISTOPHER CLARK ,  MARTIN ROY CHRISTIAN ,  COHEN EDWARD AARON

IPC: A61M1/00 ,  A61F9/00

Abstract: Devices can be implanted in an eye to treat glaucoma and/or dry eye. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. The body can include a radiused distal edge. A distal end portion of the body can be laterally flared. The body can include a mid-body portion that is laterally narrower than distal and proximal end portions of the body. Methods of treating glaucoma and/or dry eye, wherein the device is implanted in the sclera of an afflicted eye, are also described.

公开(公告)号：AU2016353229A1

公开(公告)日：2018-05-31

申请号：AU2016353229

申请日：2016-11-11

Applicant: MICROOPTX INC

Inventor： MARTIN ROY CHRISTIAN ,  PULLING CHRISTOPHER CLARK ,  MARTIN CHRISTOPHER THOMAS ,  BROWN J DAVID

IPC: A61B3/12 ,  A61B5/1455 ,  A61B5/1459

Abstract: A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.

公开(公告)号：CA3029600A1

公开(公告)日：2018-01-11

申请号：CA3029600

申请日：2017-07-05

Applicant: MICROOPTX INC

Inventor： BROWN J DAVID ,  PULLING CHRISTOPHER CLARK ,  MARTIN ROY CHRISTIAN ,  COHEN EDWARD AARON

IPC: A61F9/007

Abstract: Devices can be implanted in an eye to treat glaucoma and/or dry eye. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. The body can include a radiused distal edge. A distal end portion of the body can be laterally flared. The body can include a mid-body portion that is laterally narrower than distal and proximal end portions of the body. Methods of treating glaucoma and/or dry eye, wherein the device is implanted in the sclera of an afflicted eye, are also described.

公开(公告)号：CA3005052A1

公开(公告)日：2017-05-18

申请号：CA3005052

申请日：2016-11-11

Applicant: MICROOPTX INC

Inventor： MARTIN ROY CHRISTIAN ,  PULLING CHRISTOPHER CLARK ,  MARTIN CHRISTOPHER THOMAS ,  BROWN J DAVID

IPC: A61B3/12 ,  A61B5/1455 ,  A61B5/1459

Abstract: A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.